TickerFactsScreenerDevelopers

SINOVAC BIOTECH LTD (SVA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $32.89M2009: $74.95M2010: $101.58M2011: $104.29M2012: $91.22M2013: $106.52M2014: $89.79M2015: $63.83M2016: $62.43M2017: $114.42M2018: $158.17M2019: $152.72M2020: $1.04B2021: $11.61B2022: $3.88B2023: $1.12B2024: $335.27M2025: $488.25M$488.25M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$488.25M+45.6%
2024$335.27M-70.2%
2023$1.12B-71.0%
2022$3.88B-66.6%
2021$11.61B+1015.2%
2020$1.04B+581.7%
2019$152.72M-3.4%
2018$158.17M+38.2%
2017$114.42M+83.3%
2016$62.43M-2.2%
2015$63.83M-28.9%
2014$89.79M-15.7%
2013$106.52M+16.8%
2012$91.22M-12.5%
2011$104.29M+2.7%
2010$101.58M+35.5%
2009$74.95M+127.9%
2008$32.89M—